Description

Cortineff (fludrocortisone acetate) tablets 0.1 mg. №20

Ingredients

Active ingredient: Fludrocortisone acetate 0.1 mg per tablet.

Dosage

Dosage: The usual dose is 0.1 to 0.2 mg daily, taken orally.

Indications

Indicated for:

• Primary adrenocortical insufficiency (Addison’s disease)
• Salt-losing adrenogenital syndrome

Contraindications

Contraindications:

• Hypersensitivity to fludrocortisone acetate
• Systemic fungal infections

Directions

Directions:

• Take as directed by your healthcare provider
• Do not exceed the recommended dose

Scientific Evidence

Fludrocortisone acetate is a synthetic corticosteroid that primarily acts by enhancing sodium reabsorption in the distal tubules of the kidney. This action leads to increased blood volume and improved blood pressure in patients with adrenal insufficiency. Studies have shown that fludrocortisone is effective in managing salt-losing adrenogenital syndrome and primary adrenocortical insufficiency.

Clinical trials have demonstrated the efficacy of fludrocortisone acetate in improving symptoms and quality of life in patients with Addison’s disease. Research also suggests that fludrocortisone plays a crucial role in maintaining electrolyte balance and preventing adrenal crises in affected individuals.

Additional Information

It is important to monitor blood pressure, electrolyte levels, and weight regularly while taking fludrocortisone acetate to ensure optimal treatment outcomes. Consult your healthcare provider for personalized dosing instructions and potential drug interactions.

Overall, Cortineff (fludrocortisone acetate) tablets 0.1 mg. №20 offer a reliable treatment option for individuals with adrenal insufficiency, backed by scientific evidence and clinical experience.